Controlled release dosage form with enhanced pharmacokinetics
US10532031B2 · kind B2 · utility
0Cited by
23References
37Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 2, 2018 |
| Grant date | Jan 14, 2020 |
| Priority date | — |
| Expiry date | Nov 2, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/2886
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a simple and improved dosage form that is capable of providing a controlled release of GABAB receptor agonist contained in the core thereof. The invention also provides methods of administering the dosage form and of treating conditions that are therapeutically responsive to GABAB receptor agonist.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.